CAR-T Cell Therapy - personalized cellular Immunotherapy in 2022

被引:0
|
作者
Niebling, Janina [1 ]
Bethge, Wolfgang [2 ]
Lengerke, Claudia [3 ,4 ]
机构
[1] Univ Klinikum Tubingen, Qualitatskontrolle Leukapherese Med Klin 2, Tubingen, Germany
[2] Univ Klinikum Tubingen, Zentrums Klin Studien, Tubingen, Germany
[3] Med Fak Tubingen, Tubingen, Germany
[4] Eberhard Karis Univ Tubingen, Humanmed, Tubingen, Germany
关键词
CAR T cells; chimeric antigen receptor T cells; real world data; registration studies;
D O I
10.1055/a-1932-8145
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chimeric antigen receptor T cells (CAR T cells) are genetically modified autologous or allogeneic T lymphocytes that target specific antigens and can be used, for example, to fight tumor cells. The registration studies show a high response and remission rate in massively pre-treated patients with aggressive B-cell lymphomas, acute lymphoblastic leukemia or multiple myeloma. The article presents the indications for approval, the clinical implementation and the management of side effects of CAR cell therapy.
引用
收藏
页码:1552 / 1561
页数:10
相关论文
共 50 条
  • [21] Opportunities for CAR-T Cell Immunotherapy in HIV Cure
    Campos-Gonzalez, Gerard
    Martinez-Picado, Javier
    Velasco-Hernandez, Talia
    Salgado, Maria
    VIRUSES-BASEL, 2023, 15 (03):
  • [22] Nanosensors in clinical development of CAR-T cell immunotherapy
    Trang Anh Nguyen-Le
    Bartsch, Tabea
    Wodtke, Robert
    Brandt, Florian
    Arndt, Claudia
    Feldmann, Anja
    Bojorquez, Diana Isabel Sandoval
    Roig, Arnau Perez
    Ibarlucea, Bergoi
    Lee, Seungho
    Baek, Chan-Ki
    Cuniberti, Gianaurelio
    Bergmann, Ralf
    Puentes-Cala, Edinson
    Soto, Javier Andres
    Kurien, Biji T.
    Bachmann, Michael
    Baraban, Larysa
    BIOSENSORS & BIOELECTRONICS, 2022, 206
  • [23] A roadmap to the development of CAR-T cell immunotherapy in Europe
    B, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S111 - S111
  • [24] Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
    Brown, Kevin
    Seftel, Matthew D.
    Hay, Kevin A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (33) : E1300 - E1302
  • [25] Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T
    Crees, Zachary D.
    Ghobadi, Armin
    CANCERS, 2021, 13 (20)
  • [26] CAR-T Cell Therapy for T-Cell Malignancies
    Testa, Ugo
    Chiusolo, Patrizia
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [27] Teaming up for CAR-T cell therapy
    Waesch, Ralph
    Munder, Markus
    Marks, Reinhard
    HAEMATOLOGICA, 2019, 104 (12) : 2335 - 2336
  • [28] Leukapheresis for CAR-T cell production and therapy
    Pessach, Ilias
    Nagler, Arnon
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (06)
  • [29] Advances in Universal CAR-T Cell Therapy
    Lin, Haolong
    Cheng, Jiali
    Mu, Wei
    Zhou, Jianfeng
    Zhu, Li
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [30] Nonlinear dynamics of CAR-T cell therapy
    Fassoni, Artur C.
    Braga, Denis C.
    CHAOS SOLITONS & FRACTALS, 2025, 191